Ohio AG Calls For ‘Immediate Legislative Action’ Against PBMs
Published by Inside Health Policy
Ohio Attorney General Dave Yost (R) on Monday (April 22) called for the Ohio legislature to enact four policies targeting spread pricing practices by pharmacy benefit managers that would route all state drug purchases through a single PBM contract, give the state auditor unrestricted authority to review all PBM drug contracts, make PBMs fiduciaries and ban nondisclosure agreements regarding drug pricing with the state. A day before, Ohio pharmacist researchers published research that suggests spread pricing practices in that state might have benefited both PBMs and specialty pharmacies.
Ohio is at the forefront of the fight over spread pricing on generic drugs in Medicaid. Ohio’s investigation of PBM spread pricing practices inspired a federal investigation, and several states have followed Ohio’s lead.
Yost’s proposal to make PBMs fiduciaries is similar to the Trump administration’s suggestion last year that Congress make PBMs legally responsible for putting the interests of their clients over their own interests. That fiduciary responsibility would forbid PBMs from accepting payments from drug makers.
“PBMs have taken advantage of the lack of transparency and lack of centralization to the detriment of Ohio taxpayers,” Yost said in a statement. “This must stop. Centralization will allow for the comprehensive review of prices across the entire drug purchase portfolio to eliminate this problem.”
In March, Yost sued OptumRx over its contract with the state Bureau of Workers’ Compensation. His administration accuses the PBM of overcharging the state nearly $16 million. Yost said Monday that his office is investigating seven other PBM contracts with the Department of Medicaid, the Department of Administrative Services, the Ohio Public Employees Retirement System, the Ohio State Highway Patrol, the School Employees Retirement System of Ohio, the State Teachers Retirement System of Ohio and the Ohio Police and Fire Pension Fund.
State investigations of spread pricing inspired Senate Finance Chair Chuck Grassley (R-IA) and ranking Democrat Ron Wyden (OR) to ask an HHS watchdog to investigate the practice on a national level. The senators specifically mentioned audits conducted in Ohio, Pennsylvania and Kentucky.
Click here to see the original article on the Inside Health Policy website.
Recent Posts
-
SCPC Sends Reasonable & Relevant “Pre-Comment” Letter to CMS
The Senior Care Pharmacy Coalition (SCPC) submitted comments on the Calendar Year 2027 Home Health Prospective Payment System proposed rule, focusing on proposed changes to Medicare enrollment provisions. In its comments, SCPC applauded the work of CMS to address fraud and waste in the system while protecting services for those who need them most. SCPC urged CMS […]
-
SCPC Submits Second Round of Comments to Healthcare Advisory Committee
The Senior Care Pharmacy Coalition submitted comments yesterday to the Healthcare Advisory Committee (HAC). The HAC is a group of experts charged with delivering strategic recommendations directly to the HHS Secretary and CMS Administrator to improve how care is financed and delivered across Medicare, Medicaid and the Children’s Health Insurance Program (CHIP), and the Health […]
-
SCPC Responds to Senate Finance Committee Request for Information on Commonsense Policy Options to Lower Drug Prices for Patients
The Senior Care Pharmacy Coalition (SCPC), the leading voice for the nation’s long-term care (LTC) pharmacy community, submitted comments to the Senate Finance Committee’s Request for Information (RFI) seeking input on commonsense policy options to lower drug prices for patients. “SCPC supports the Committee’s focus on reducing prescription drug costs while preserving beneficiary access and […]
Stay Connected
Get the latest news and updates on issues impacting the long-term care pharmacy community.